News

Viatris Inc. , a global healthcare company, today announced the launch in Canada of Gen-Clozapine orally disintegrating tablets (ODT) (12.5 mg, 25 mg, 50 mg, 100 mg and 200 mg), providing a new ...
Axsome Therapeutics, Inc. (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into a settlement ...
Videos available at [ Key points A 94-year-old man with parkinsonism, followed in our geriatric medicine clinic, presented for routine follow-up, during which his wife reported that he had a ...
Swallowable sensors provide continuously measured physiological data from the digestive tract, which can indicate diseases.
But there’s no denying that it's seen a surge of interest in recent years. Ketamine clinics—or treatment centers that offer ...
Therein lay the problem for Rosenhan. Once the patients had this label of a psychiatric illness, it was hard to shift. The ...
A surgical implant that reduces cravings for alcohol is helping free patients and their families from the pain of addiction.
In Chennai’s punishing summer, greater attention needs to be paid to the medicine cabinet. The Hindu Downtown talks to ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
Detailed price information for Sunshine Biopharma (SBFM-Q) from The Globe and Mail including charting and trades.
This came after MSN Laboratories presented their proposal for a grant of permission to manufacture and market Lurasidone Hydrochloride Tablets 60 mg and 120 mg (Additional Strength) for the treatment ...
If you’re on the hunt for the ultimate portable gaming machine in 2025, tablets are no longer just large-screen companions for streaming and browsing — they’ve become powerful gaming devices ...